Sign In  |  Register  |  About Walnut Creek Guide  |  Contact Us

Walnut Creek, CA
September 01, 2020 1:43pm
7-Day Forecast | Traffic

  • Search Hotels in Walnut Creek Guide

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about RHHBY

Recent news which mentions RHHBY

< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Novo Nordisk, Eli Lilly Could Face Downward Pressure Despite Market Dominance From Potentially 16 New Obesity Drugs: See The Names
Tickers ALT AMGN LLY NEWS
Tags Briefs ALT General
From Benzinga
Why Is Cancer Focused Tempest Therapeutics Stock Trading Higher On Thursday?
Tickers NEWS RHHBY TPST
Tags RHHBY General Movers
From Benzinga
Nano-Cap Bio-Path Takes Plunge In Weight Loss Race, Initiates Obesity Program With Drug Candidate Under Development For Blood Cancer
Tickers ABBV BPTH NEWS RHHBY
Tags why it's moving Briefs News
From Benzinga
Scholar Rock's Muscle Wasting Drug Excels In Pivotal Trial, Plans FDA Submission Next Year
Tickers BIIB NEWS RHHBY SRRK
Tags Health Care BIIB Biotech
From Benzinga
2 Artificial Intelligence Stocks That Could Deliver Explosive Gains
Tickers RHHBY RXRX SNY SOUN
Tags RHHBY BAYR/Y Recent Press Releases
From Motley Fool
Economist Justin Wolfers Points To Obesity Rate Decline As Ozempic And Wegovy Spur Historic Shift In Fight Against Obesity — Has US Reached A Turning Point?
Tickers LLY NEWS NVO RHHBY
Tags Justin Wolfers Kaustubh Bagalkote News
From Benzinga
3 Top Stocks That Could Still Rocket Higher in 2024
Tickers BBIO PFE PTCT RHHBY
Tags RHHBY Recent Press Releases PTCT
From Motley Fool
Roche Fast-Tracks Obesity Drug Development, Eyes Over $3B Sales Potential
Tickers LLY NEWS NVO RHHBY
Tags Eurozone Stories That Matter Top Stories
From Benzinga
Roche's Antiviral Drug Reduces Transmission Of Influenza Viruses, Late-Stage Study Shows
Tickers NEWS RHHBY
Tags Biotech Large Cap Briefs
From Benzinga
1 Telemedicine Stock I Wouldn't Touch With a 10-Foot Pole (Hint: It's Not Teladoc)
Tickers ALT AMZN HIMS LLY
Tags PFE LLY NVO
From Motley Fool
Back-To-Back FDA Approvals For Roche's Two Under-The-Skin Injections
Tickers NEWS RHHBY
Tags Briefs News General
From Benzinga
Viking Therapeutics: A Bad Result for Roche's Weight-Management Pill Is Great News for Oral VK2735
Tickers RHHBY VKTX
Tags RHHBY Recent Press Releases VKTX
From Motley Fool
Why Roche Holdings Stock Withered on Wednesday
Tickers LLY NVO RHHBY
Tags Market News LLY NVO
From Motley Fool
Fulcrum Therapeutics Upgraded: BofA Debates Pivotal Study Success For Losmapimod In Rare Genetic Muscle Disease
Tickers FULC NEWS RHHBY RNA
Tags Market News Analyst Ratings Benzinga
From Benzinga
Enliven Therapeutics' Leukemia Candidate Could Challenge Pfizer, AstraZeneca In Broader Target Market: Analyst
Tickers AZN BMY ELVN NEWS
Tags ELVN Expert Ideas Top Stories
From Benzinga
Moderna And BioNTech Bet On Personalized Cancer Vaccines To Revive Fortunes After Dwindling COVID-19 Vaccine Sales
Tickers BNTX MRK MRNA NEWS
Tags MRK Market News Media
From Benzinga
Diagnostic Giants Labcorp, Roche To Ramp Up Testing Capacity Amid Global Concerns Over New Mpox Strain
Tickers ABT BVNKF BVNRY DGX
Tags Top Stories Mpox RHHBY
From Benzinga
Novo Nordisk and Eli Lilly Could Have a Big Rival in the GLP-1 Market in a Few Years
Tickers LLY NVO RHHBY
Tags NVO LLY RHHBY
From Motley Fool
Roche Misses Out On Weight-Loss Blockbuster Drug, Now Playing Catch-Up In Booming Market
Tickers LLY NEWS NVO RHHBY
Tags LLY NVO Benzinga
From Benzinga
Why Is Small-Cap Tempest Therapeutics Stock Trading Higher On Thursday?
Tickers NEWS RHHBY TPST
Tags Health Care Small Cap Biotech
From Benzinga
Prediction: This Company Will Disrupt Eli Lilly and Novo Nordisk in the Weight Loss Market (Hint: It's Not Pfizer)
Tickers LLY NVO RHHBY
Tags LLY NVO RHHBY
From Motley Fool
Cancer-Focused Syros Pharmaceuticals Stops Mid-Stage Leukemia Combo Therapy Study, Cites Disappointing Unexpected Outcome
Tickers ABBV BMY NEWS RHHBY
Tags SYRS Market News Benzinga
From Benzinga
Merck Stops Lung Cancer Study For Keytruda Combo Due To Ineffective Results, Side Effects
Tickers MRK NEWS RHHBY
Tags Benzinga Market News MRK
From Benzinga
Here's Why Eli Lilly Stock Dropped 12% Last Month
Tickers AMGN LLY NVO PFE
Tags PFE AMGN VKTX
From Motley Fool
Roche Considers Selling Cancer Data Specialist Flatiron Health Business, Highlights Challenges With Start-Up Acquisitions
Tickers C GOOG GOOGL NEWS
Tags GOOGL Stories That Matter RHHBY
From Benzinga
Bristol Myers Squibb Terminates Cancer Drug Development Program With Agenus
Tickers AGEN BMY MRK NEWS
Tags Benzinga Market News MRK
From Benzinga
Are Eli Lilly and Novo Nordisk Too Expensive For You? Here Are 4 Other Potential Weight Loss Stocks You May Want to Consider Right Now.
Tickers ALT LLY NVO PFE
Tags LLY VKTX NVO
From Motley Fool
Weight Loss Drug Stocks Just Took a Hit. Should You Buy the Stock That Caused It?
Tickers LLY NVO RHHBY
Tags Market News LLY NVO
From Motley Fool
Novo Nordisk's Stock Dips In Pre-Market Despite Winning UK's Approval Of Weight Loss Drug: What's Going On
Tickers LLY NEWS NVO PFE
Tags UK RHHBY General
From Benzinga
Look Out, Eli Lilly and Novo Nordisk: Could Roche Be the Obesity Drug Stock to Really Watch?
Tickers LLY NVO RHHBY
Tags NVO LLY Recent Press Releases
From Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 WalnutCreekGuide.com & California Media Partners, LLC. All rights reserved.